Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder

Hua Lin Kao, Chiung Ru Lai, Hsiang Ling Ho, Chin Chen Pan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aims: For patients with carcinoma of the urinary bladder and uterine cervix, distinguishing between metastasis and a second primary carcinoma has significant prognostic and therapeutic implications. The aim of this study was to investigate the prevalence of high-risk human papillomavirus (HR-HPV) in cervical carcinoma with secondary involvement of the bladder and primary bladder carcinoma, in order to explore whether the detection of HR-HPV could help to differentiate between the two. Methods and results: Paired bladder and cervix carcinoma specimens from 37 patients with cervical carcinoma with bladder involvement, four patients with bladder carcinoma with uterine cervical involvement and two patients with double primaries were studied with quantitative multiplex polymerase chain reaction and chromogenic in-situ hybridization. Three hundred and seventy-five bladder carcinomas and 220 cervical carcinomas were analysed as controls. All cases of cervical carcinoma with bladder involvement showed concordant HR-HPV-positive patterns. The four cases of bladder carcinoma with uterine involvement were negative for HR-HPV. HR-HPV was detected in the cervical carcinoma but not in the bladder carcinoma of the patients with double primaries. HR-HPV was detected in 91.9% of cervical carcinomas but in none of the bladder carcinomas in the control group. Conclusions: Molecular typing for HR-HPV detection is useful to distinguish bladder carcinoma from secondary involvement of cervical carcinoma.

Original languageEnglish
Pages (from-to)513-519
Number of pages7
JournalHistopathology
Volume68
Issue number4
DOIs
Publication statusPublished - Mar 1 2016
Externally publishedYes

Fingerprint

Molecular Typing
Urinary Bladder
Carcinoma
Cervix Uteri
Multiplex Polymerase Chain Reaction

Keywords

  • Bladder cancer
  • Cervical squamous cell carcinoma
  • Chromogenic in-situ hybridization
  • High-risk human papillomavirus
  • Quantitative multiplex PCR

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

@article{ef769d4ef7644a6181e269d1a27731d4,
title = "Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder",
abstract = "Aims: For patients with carcinoma of the urinary bladder and uterine cervix, distinguishing between metastasis and a second primary carcinoma has significant prognostic and therapeutic implications. The aim of this study was to investigate the prevalence of high-risk human papillomavirus (HR-HPV) in cervical carcinoma with secondary involvement of the bladder and primary bladder carcinoma, in order to explore whether the detection of HR-HPV could help to differentiate between the two. Methods and results: Paired bladder and cervix carcinoma specimens from 37 patients with cervical carcinoma with bladder involvement, four patients with bladder carcinoma with uterine cervical involvement and two patients with double primaries were studied with quantitative multiplex polymerase chain reaction and chromogenic in-situ hybridization. Three hundred and seventy-five bladder carcinomas and 220 cervical carcinomas were analysed as controls. All cases of cervical carcinoma with bladder involvement showed concordant HR-HPV-positive patterns. The four cases of bladder carcinoma with uterine involvement were negative for HR-HPV. HR-HPV was detected in the cervical carcinoma but not in the bladder carcinoma of the patients with double primaries. HR-HPV was detected in 91.9{\%} of cervical carcinomas but in none of the bladder carcinomas in the control group. Conclusions: Molecular typing for HR-HPV detection is useful to distinguish bladder carcinoma from secondary involvement of cervical carcinoma.",
keywords = "Bladder cancer, Cervical squamous cell carcinoma, Chromogenic in-situ hybridization, High-risk human papillomavirus, Quantitative multiplex PCR",
author = "Kao, {Hua Lin} and Lai, {Chiung Ru} and Ho, {Hsiang Ling} and Pan, {Chin Chen}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/his.12769",
language = "English",
volume = "68",
pages = "513--519",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder

AU - Kao, Hua Lin

AU - Lai, Chiung Ru

AU - Ho, Hsiang Ling

AU - Pan, Chin Chen

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aims: For patients with carcinoma of the urinary bladder and uterine cervix, distinguishing between metastasis and a second primary carcinoma has significant prognostic and therapeutic implications. The aim of this study was to investigate the prevalence of high-risk human papillomavirus (HR-HPV) in cervical carcinoma with secondary involvement of the bladder and primary bladder carcinoma, in order to explore whether the detection of HR-HPV could help to differentiate between the two. Methods and results: Paired bladder and cervix carcinoma specimens from 37 patients with cervical carcinoma with bladder involvement, four patients with bladder carcinoma with uterine cervical involvement and two patients with double primaries were studied with quantitative multiplex polymerase chain reaction and chromogenic in-situ hybridization. Three hundred and seventy-five bladder carcinomas and 220 cervical carcinomas were analysed as controls. All cases of cervical carcinoma with bladder involvement showed concordant HR-HPV-positive patterns. The four cases of bladder carcinoma with uterine involvement were negative for HR-HPV. HR-HPV was detected in the cervical carcinoma but not in the bladder carcinoma of the patients with double primaries. HR-HPV was detected in 91.9% of cervical carcinomas but in none of the bladder carcinomas in the control group. Conclusions: Molecular typing for HR-HPV detection is useful to distinguish bladder carcinoma from secondary involvement of cervical carcinoma.

AB - Aims: For patients with carcinoma of the urinary bladder and uterine cervix, distinguishing between metastasis and a second primary carcinoma has significant prognostic and therapeutic implications. The aim of this study was to investigate the prevalence of high-risk human papillomavirus (HR-HPV) in cervical carcinoma with secondary involvement of the bladder and primary bladder carcinoma, in order to explore whether the detection of HR-HPV could help to differentiate between the two. Methods and results: Paired bladder and cervix carcinoma specimens from 37 patients with cervical carcinoma with bladder involvement, four patients with bladder carcinoma with uterine cervical involvement and two patients with double primaries were studied with quantitative multiplex polymerase chain reaction and chromogenic in-situ hybridization. Three hundred and seventy-five bladder carcinomas and 220 cervical carcinomas were analysed as controls. All cases of cervical carcinoma with bladder involvement showed concordant HR-HPV-positive patterns. The four cases of bladder carcinoma with uterine involvement were negative for HR-HPV. HR-HPV was detected in the cervical carcinoma but not in the bladder carcinoma of the patients with double primaries. HR-HPV was detected in 91.9% of cervical carcinomas but in none of the bladder carcinomas in the control group. Conclusions: Molecular typing for HR-HPV detection is useful to distinguish bladder carcinoma from secondary involvement of cervical carcinoma.

KW - Bladder cancer

KW - Cervical squamous cell carcinoma

KW - Chromogenic in-situ hybridization

KW - High-risk human papillomavirus

KW - Quantitative multiplex PCR

UR - http://www.scopus.com/inward/record.url?scp=84957959748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957959748&partnerID=8YFLogxK

U2 - 10.1111/his.12769

DO - 10.1111/his.12769

M3 - Article

C2 - 26152613

AN - SCOPUS:84957959748

VL - 68

SP - 513

EP - 519

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 4

ER -